Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=240) stratified by the immunoparesis status at dia...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Eli Muchtar, Angela Dispenzieri, Shaji K. Kumar, David Dingli, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Rajshekhar Chakraborty, Stephen Russell, John A. Lust, Yi Lin, Ronald S. Go, Steven Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2016-09-01
Online Access:	https://haematologica.org/article/view/7823